
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.280 | 1.430 | 1.150 |
Shares | 99.720 | 99.720 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 5.479 | 16.924 |
Price to Book | 0.877 | 2.774 |
Price to Sales | 0.938 | 2.172 |
Price to Cash Flow | 7.972 | 10.634 |
Dividend Yield | 1.781 | 2.765 |
5 Years Earnings Growth | - | 11.997 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 75.260 | 12.025 |
Real Estate | 11.850 | 4.472 |
Basic Materials | 5.120 | 9.122 |
Consumer Defensive | 4.820 | 7.912 |
Consumer Cyclical | 2.190 | 12.082 |
Technology | 0.770 | 20.629 |
Number of long holdings: 37
Number of short holdings: 24
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Tilray | US88688T1007 | 14.49 | 1.380 | -6.12% | |
Curaleaf | CA23126M1023 | 10.88 | 4.51 | -3.43% | |
Innovative Industrial Properties | US45781V1017 | 9.65 | 56.66 | +0.64% | |
Jazz Pharma | IE00B4Q5ZN47 | 9.21 | 127.75 | +1.28% | |
Green Thumb | CA39342L1085 | 8.73 | 11.920 | -1.57% | |
Verano Holdings | CA92338D1015 | 8.21 | 1.70 | +3.03% | |
Cronos | CA22717L1013 | 6.31 | 2.600 | 0.00% | |
Trulieve Cannabis | CA89788C1041 | 5.56 | 12.07 | -3.05% | |
Scotts Miracle-Gro | US8101861065 | 5.11 | 61.22 | -0.07% | |
Cresco Labs | CA22587M1068 | 3.77 | 2.07 | +0.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IBI Up to 3 Yrs 80 20 | 848.2M | 7.24 | 7.55 | 4.53 | ||
IBI 70 30 | 733.8M | 11.34 | 9.71 | - | ||
I.B.I. NASDAQ 100 Basket | 717.1M | 2.85 | 21.63 | 16.28 | ||
IBI 85 15 | 389.3M | 6.69 | 6.11 | 3.69 | ||
I.B.I Forex Hedged USA Basket | 331.7M | 4.51 | 12.00 | 10.25 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review